Elevated citrate levels in non-alcoholic fatty liver disease: the potential of citrate to promote radical production. (Q39136534)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23792160%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Elevated citrate levels in non-alcoholic fatty liver disease: the potential of citrate to promote radical production (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23792160%20AND%20SRC:MED&resulttype=core&format=json

metabolic dysfunction–associated steatotic liver disease

3 March 2020

main subject

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23792160%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Jaap A. Bakker

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23792160%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Bregje van de Wier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23792160%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Jiska M Balk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23792160%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Dimosthenis Giamouridis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23792160%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Bertine C Bast

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23792160%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Gertjan J M den Hartog

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23792160%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Ger H Koek

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23792160%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Aalt Bast

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23792160%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

19 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23792160%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23792160%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

587

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23792160%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23792160%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

2461-2466

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23792160%20AND%20SRC:MED&resulttype=core&format=json

The epidemiology of nonalcoholic fatty liver disease: a global perspective

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.019

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.019

The role of oxidative stress in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.019

Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.019

Measurement of citrate in urine using liquid chromatography tandem mass spectrometry: comparison with an enzymatic method

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.019

Protective effects of panduratin A against oxidative damage of tert-butylhydroperoxide in human HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.019

Spin trapping: ESR parameters of spin adducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.019

Variability of the Fenton reaction characteristics of the EDTA, DTPA, and citrate complexes of iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.019

Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.019

HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.019

Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.019

Iron and steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.019

Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.019

Ferritin as a source of iron for oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.06.019